Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain

BACKGROUND The dopamine (DA) neurotransmission has been implicated in fundamental brain functions, exemplified by movement controls, reward-seeking, motivation, and cognition. Although dysregulation of DA neurotransmission in the striatum is known to be involved in diverse neuropsychiatric disorders, it is yet to be clarified whether components of the DA transmission, such as synthesis, receptors, and reuptake are coupled with each other to homeostatically maintain the DA neurotransmission. The purpose of this study was to investigate associations of the DA synthesis capacity with the availabilities of DA transporters and D2 receptors in the striatum of healthy subjects. METHODS First, we examined correlations between the DA synthesis capacity and DA transporter availability in the caudate and putamen using PET data with L-[β-11C]DOPA and [18F]FE-PE2I, respectively, acquired from our past dual-tracer studies. Next, we investigated relationships between the DA synthesis capacity and D2 receptor availability employing PET data with L-[β-11C]DOPA and [11C]raclopride, respectively, obtained from other previous dual-tracer assays. RESULTS We found a significant positive correlation between the DA synthesis capacity and DA transporter availability in the putamen, while no significant correlations between the DA synthesis capacity and D2 receptor availability in the striatum. CONCLUSION The intimate association of the DA synthesis rate with the presynaptic reuptake of DA indicates homeostatic maintenance of the baseline synaptic DA concentration. In contrast, the total abundance of D2 receptors, which consist of presynaptic autoreceptors and postsynaptic modulatory receptors, may not have an immediate relationship to this regulatory mechanism.

[1]  F. Yasuno,et al.  Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia. , 2004, The American journal of psychiatry.

[2]  J. Kwon,et al.  Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study , 2017, Neuropsychopharmacology.

[3]  Daniella J. Furman,et al.  Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release , 2017, Neuropsychopharmacology.

[4]  R. Barker,et al.  11C‐PE2I and 18F‐Dopa PET for assessing progression rate in Parkinson's: A longitudinal study , 2018, Movement disorders : official journal of the Movement Disorder Society.

[5]  R. Roth,et al.  Autoreceptor Regulation of Dopamine Synthesis , 1990, Annals of the New York Academy of Sciences.

[6]  Robert M. Kessler,et al.  Midbrain Dopamine Receptor Availability Is Inversely Associated with Novelty-Seeking Traits in Humans , 2008, The Journal of Neuroscience.

[7]  L. Reneman,et al.  Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers , 2000, European Journal of Nuclear Medicine.

[8]  Alain Dagher,et al.  Stress-Induced Dopamine Release in Humans at Risk of Psychosis: a [11C]Raclopride PET Study , 2008, Neuropsychopharmacology.

[9]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[10]  H. Nijhout,et al.  Passive and active stabilization of dopamine in the striatum , 2009 .

[11]  D. Zald,et al.  Dopaminergic Network Differences in Human Impulsivity , 2010, Science.

[12]  Mattia Veronese,et al.  A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia , 2017, JAMA psychiatry.

[13]  J. Doyon,et al.  Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Murray,et al.  Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. , 2011, The American journal of psychiatry.

[15]  R. Gainetdinov,et al.  Dopaminergic Transmission in the Rat Striatum in Vivo in Conditions of Pharmacological Modulation , 2002, Neuroscience and Behavioral Physiology.

[16]  C. P. Ford The role of D2-autoreceptors in regulating dopamine neuron activity and transmission , 2014, Neuroscience.

[17]  C. Nemeroff The Biochemical Basis of Neuropharmacology, 8th ed. , 2004 .

[18]  J. Hietala,et al.  Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. , 2000, The American journal of psychiatry.

[19]  Marie-Claude Asselin,et al.  Elevated striatal dopamine function linked to prodromal signs of schizophrenia. , 2009, Archives of general psychiatry.

[20]  Harumasa Takano,et al.  Regional dopamine synthesis in patients with schizophrenia using L-[β-11C]DOPA PET , 2009, Schizophrenia Research.

[21]  T. Woodward,et al.  Dopamine, cognitive biases and assessment of certainty: A neurocognitive model of delusions. , 2017, Clinical psychology review.

[22]  H. Nijhout,et al.  Theoretical Biology and Medical Modelling Open Access Homeostatic Mechanisms in Dopamine Synthesis and Release: a Mathematical Model , 2022 .

[23]  V. Sossi,et al.  In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease , 2000, Annals of neurology.

[24]  J. Hietala,et al.  Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients , 1995, The Lancet.

[25]  C. Halldin,et al.  Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[&bgr;-11C]DOPA and [18F]FE-PE2I in humans , 2014, Nuclear medicine communications.

[26]  N. Kawashima,et al.  Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug , 2012, Annals of General Psychiatry.

[27]  V. Shahrezaei,et al.  Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance , 2020, Biological Psychiatry.

[28]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Yen F. Tai,et al.  Compulsive drug use linked to sensitized ventral striatal dopamine transmission , 2006, Annals of neurology.

[30]  Harumasa Takano,et al.  Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter. , 2009, Journal of psychiatric research.

[31]  B. Långström,et al.  Brain kinetics of L-[Β-11 C]DOPA in humans studied by positron emission tomography , 2005, Journal of Neural Transmission / General Section JNT.

[32]  Hidehiko Takahashi,et al.  Effects of Dopamine D2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-11C]DOPA , 2012, PloS one.

[33]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  K. Lewandowski,et al.  Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions. , 2007, Harvard review of psychiatry.

[35]  S. Houle,et al.  Influence of l-dopa and pramipexole on striatal dopamine transporter in early PD , 2001, Neurology.

[36]  Hidehiko Takahashi,et al.  Effects of the Antipsychotic Risperidone on Dopamine Synthesis in Human Brain Measured by Positron Emission Tomography with l-[β-11C]DOPA: A Stabilizing Effect for Dopaminergic Neurotransmission? , 2009, The Journal of Neuroscience.

[37]  A. Heinz,et al.  Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  Andrea Anzalone,et al.  Dual Control of Dopamine Synthesis and Release by Presynaptic and Postsynaptic Dopamine D2 Receptors , 2012, The Journal of Neuroscience.

[39]  Paul Cumming,et al.  The Impact of Dopamine on Aggression: An [18F]-FDOPA PET Study in Healthy Males , 2013, The Journal of Neuroscience.

[40]  F. Mottaghy,et al.  Acute and Sustained Effects of Methylphenidate on Cognition and Presynaptic Dopamine Metabolism: An [18F]FDOPA PET Study , 2014, The Journal of Neuroscience.

[41]  L. Mucke,et al.  A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.

[42]  B. Långström,et al.  Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography , 2005, Journal of Neural Transmission.

[43]  Federico Turkheimer,et al.  Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. , 2013, Brain : a journal of neurology.

[44]  J. Delay,et al.  [Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)]. , 1952, Annales medico-psychologiques.

[45]  A. Grace Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression , 2016, Nature Reviews Neuroscience.

[46]  D. Siskind,et al.  Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[47]  J. Lieberman,et al.  Provocative tests with psychostimulant drugs in schizophrenia , 2004, Psychopharmacology.

[48]  Tobias U. Hauser,et al.  Endogenous fluctuations in the dopaminergic midbrain drive behavioral choice variability , 2019, Proceedings of the National Academy of Sciences.

[49]  R. Murray,et al.  Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. , 2012, The American journal of psychiatry.

[50]  L. Vanderschuren,et al.  Critical Involvement of Dopaminergic Neurotransmission in Impulsive Decision Making , 2006, Biological Psychiatry.

[51]  F. Bloom,et al.  The Biochemical Basis of Neuropharmacology , 1976 .

[52]  J. Wickens,et al.  Role of homeostatic feedback mechanisms in modulating methylphenidate actions on phasic dopamine signaling in the striatum of awake behaving rats , 2019, Progress in Neurobiology.

[53]  P. Garris,et al.  Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals , 1997, Brain Research.

[54]  K. Blum,et al.  Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. , 2017, Frontiers in bioscience.

[55]  J. Ferreira,et al.  The gut–brain dopamine axis: A regulatory system for caloric intake , 2012, Physiology & Behavior.

[56]  Fumitoshi Kodaka,et al.  Relation between Presynaptic and Postsynaptic Dopaminergic Functions Measured by Positron Emission Tomography: Implication of Dopaminergic Tone , 2011, The Journal of Neuroscience.

[57]  A. Patiño-García,et al.  Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment , 2007, The Pharmacogenomics Journal.

[58]  A. Egerton,et al.  Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort , 2013, Biological Psychiatry.

[59]  J. Pavía,et al.  Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism , 2005, Psychopharmacology.

[60]  V L KOZLOWSKI,et al.  Depressive symptoms. , 1959, Medical times.

[61]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[62]  D J Brooks,et al.  Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[63]  Abraham Weizman,et al.  Increased platelet vesicular monoamine transporter density in adult schizophrenia patients , 2002, European Neuropsychopharmacology.

[64]  J. Hietala,et al.  Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia , 1999, Schizophrenia Research.

[65]  Alan A. Wilson,et al.  Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone , 1993, Psychiatry Research.

[66]  S. Aoki,et al.  Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT , 2017, Annals of Nuclear Medicine.

[67]  R. Wightman,et al.  Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis 1 Published on the World Wide Web on 27 January 1998. 1 , 1998, Brain Research Reviews.

[68]  R. Wightman,et al.  Profound neuronal plasticity in response to inactivation of the dopamine transporter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  R. Murray,et al.  Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study , 2011, Molecular Psychiatry.

[70]  F. Mottaghy,et al.  The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophrenia , 2018, Psychopharmacology.

[71]  M. Grégoire,et al.  Anatomic and Biochemical Correlates of the Dopamine Transporter Ligand 11C-PE2I in Normal and Parkinsonian Primates: Comparison with 6-[18F]Fluoro-L-Dopa , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  O. Hikosaka,et al.  Differential roles of monkey striatum in learning of sequential hand movement , 1997, Experimental Brain Research.

[73]  A. Salgado,et al.  Unilateral accumbal dopamine depletion affects decision-making in a side-specific manner , 2020, Experimental Neurology.

[74]  Paul Cumming,et al.  Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. , 2005, The American journal of psychiatry.